Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Joana
Joana Assunção, Senhora Da Hora PT
| Patent application number | Description | Published |
|---|---|---|
| 20100173799 | METHOD FOR GENERATION OF IMMUNOGLOBULIN SEQUENCES - The present invention relates to a method for generating immunoglobulin sequences against cell-associated antigens, more particularly, antigens that are membrane-anchored. The invention also provides immunoglobulin sequences obtainable by the method of the invention. Specifically, the present invention relates to the generation of immunoglobulin sequences by use of DNA vaccination. More specifically, the present invention relates to generation of immunoglobulin sequences in camelids, preferably directed against cell-associated antigens, in particular antigens with multiple transmembrane spanning domains, including GPCRs and ion channels, by DNA vaccination. Furthermore, the present invention relates to said immunoglobulin sequences against cell-associated antigens, more particularly, antigens that are membrane-anchored, such as e.g. GPCRs and ion channels, more preferably ion channels. | 07-08-2010 |
Joana Assunção, Senhora Da Hora PT
| Patent application number | Description | Published |
|---|---|---|
| 20100173799 | METHOD FOR GENERATION OF IMMUNOGLOBULIN SEQUENCES - The present invention relates to a method for generating immunoglobulin sequences against cell-associated antigens, more particularly, antigens that are membrane-anchored. The invention also provides immunoglobulin sequences obtainable by the method of the invention. Specifically, the present invention relates to the generation of immunoglobulin sequences by use of DNA vaccination. More specifically, the present invention relates to generation of immunoglobulin sequences in camelids, preferably directed against cell-associated antigens, in particular antigens with multiple transmembrane spanning domains, including GPCRs and ion channels, by DNA vaccination. Furthermore, the present invention relates to said immunoglobulin sequences against cell-associated antigens, more particularly, antigens that are membrane-anchored, such as e.g. GPCRs and ion channels, more preferably ion channels. | 07-08-2010 |
Joana Coelho Tsou, Heidelberg DE
| Patent application number | Description | Published |
|---|---|---|
| 20100130788 | METHOD FOR PRODUCING AMINES - The invention relates to a process for preparing aromatic amines by catalytic hydrogenation of the corresponding nitro compounds, in particular for preparing toluenediamine by hydrogenation of dinitrotoluene, wherein hydrogenation catalysts in which a mixture of nickel, palladium and an additional element selected from the group consisting of cobalt, iron, vanadium, manganese, chromium, platinum, iridium, gold, bismuth, molybdenum, selenium, tellurium, tin and antimony is present as active component on a support are used. | 05-27-2010 |
| 20110060176 | METHOD FOR THE DEHYDROAROMATISATION OF MIXTURES CONTAINING METHANE BY REGENERATING THE CORRESPONDING CATALYSTS THAT ARE DEVOID OF PRECIOUS METAL - The present invention relates to a process for nonoxidative dehydroaromatization of aliphatic hydrocarbons by converting a reactant stream comprising aliphatic hydrocarbons in the presence of a catalyst which comprises at least one metallosilicate as a support, at least one element selected from the group of Mo, W and Re as an active component and at least one further transition metal which is not a noble metal as a dopant, wherein the catalyst is regenerated regularly with hydrogen under nonoxidative conditions. The further transition metal used is preferably Fe, Ni, Cu and Co. | 03-10-2011 |
| 20110124933 | CATALYST FOR THE DEHYDROAROMATISATION OF METHANE AND MIXTURES CONTAINING METHANE - The present invention relates to a catalyst for dehydroaromatizing C | 05-26-2011 |
| 20110275858 | METHOD FOR PRODUCING TOLUYLENEDIAMINE BY HYDROGENATING DINITROTOLUENE - A process for preparing tolylenediamine by hydrogenating dinitrotoluene with hydrogen in the presence of a suspended catalyst | 11-10-2011 |
Joana Coelho Tsou, Brussel BE
| Patent application number | Description | Published |
|---|---|---|
| 20110295039 | PROCESS FOR PREPARING TOLUENEDIAMINE BY HYDROGENATION OF DINITROTOLUENE - The invention relates to a process for the continuous preparation of toluenediamine by liquid-phase hydrogenation of dinitrotoluene by means of hydrogen in the presence of a suspended, nickel-comprising catalyst in a reactor with a product isolation unit downstream of the reactor to give a product output from the reactor comprising a liquid phase comprising toluenediamine and dinitrotoluene, in which the nickel-comprising catalyst is suspended, wherein the concentration of dinitrotoluene in the liquid phase of the product output from the reactor in the region between the reactor and the downstream product isolation unit is set to a value in the range from 1 to 200 ppm by weight, based on the total weight of the liquid phase of the product output from the reactor. | 12-01-2011 |
Joana Da Trindade, Porto Alegre BR
| Patent application number | Description | Published |
|---|---|---|
| 20100162406 | SECURITY ASPECTS OF SOA - The present description refers in particular to a computer implemented method, computer program product, and computer system for dynamic separation of duties (SoD) during workflow execution. Based on at least one policy file, at a monitoring module, at least one node to be logged from a message in a message pipe of one or more messages exchanged when executing a workflow instance may be specified. Information on the at least one logged node may be passed to an enforcer. SoD violation for the at least one logged node may be checked at the enforcer. If, for the at least one logged node, SoD is violated, action may be taken based on the at least one policy file. | 06-24-2010 |
Joana Oliveira Pais, Monte De Caparica PT
| Patent application number | Description | Published |
|---|---|---|
| 20100113765 | GALACTOSE-RICH POLYSACCHARIDE, PROCESS FOR THE PRODUCTION OF THE POLYMER AND ITS APPLICATIONS - This invention concerns a biopolymer consisting of a polysaccharide composed of galactose (50-90%), glucose (1-25%), mannose (1-25%) and rhamnose (0.5-20%), which may additionally contain, in trace amounts, xylose, fucose, ribose, arabinose and/or fructose. The galactose-rich polymer also contains non-saccharide components, namely, acyl groups. This invention also concerns a process for the production of the galactose-rich polymer, by microbial fermentation using glycerol or glycerol-rich substrates as carbon source, and recovery of the polymer from the culture broth. From the process for the production of the galactose-rich polymer results the co-production of intracellular biopolymers, namely, polyhydroxyalkanoates. This invention also concerns to the application of the galactose-rich polymer and the products of its partial or complete degradation and/or derivatization, namely, galacto-oligosaccharides, galactose, rhamnose and others, by physical, chemical and/or biological methods, in food, agricultural, textile and paper industries, pharmaceutical and cosmetic products, oil and metal recovery in mining industry, industrial waste treatment and wastewater treatment, among others. | 05-06-2010 |
Joana Sánchez Roig, Campos ES
| Patent application number | Description | Published |
|---|---|---|
| 20100222278 | USE OF LEPTIN FOR THE PREVENTION OF EXCESS BODY WEIGHT AND COMPOSITION CONTAINING LEPTIN - The invention relates to the use of leptin in the preparation of an ingestible composition for children from nursing infants to adolescents, comprising leptin at a concentration greater than 50 ng/kg for the prevention of excess weight and/or the complications associated therewith. The invention comprises the use of a fully- or partially-hydrolyzed recombinant leptin. Said ingestible composition is a supplement for developmental nutrition, contains between 0.1 and 30 micrograms/liter leptin, provides a daily dose of leptin of more than 25 ng and can take the form of a solid, i.e. a tablet, capsule or reconstitutable powder, or a liquid, i.e. a syrup or drink. | 09-02-2010 |
Joana Sánchez Roig, Campos ES
| Patent application number | Description | Published |
|---|---|---|
| 20100222278 | USE OF LEPTIN FOR THE PREVENTION OF EXCESS BODY WEIGHT AND COMPOSITION CONTAINING LEPTIN - The invention relates to the use of leptin in the preparation of an ingestible composition for children from nursing infants to adolescents, comprising leptin at a concentration greater than 50 ng/kg for the prevention of excess weight and/or the complications associated therewith. The invention comprises the use of a fully- or partially-hydrolyzed recombinant leptin. Said ingestible composition is a supplement for developmental nutrition, contains between 0.1 and 30 micrograms/liter leptin, provides a daily dose of leptin of more than 25 ng and can take the form of a solid, i.e. a tablet, capsule or reconstitutable powder, or a liquid, i.e. a syrup or drink. | 09-02-2010 |